Shortened peptides derived from Brazilian snake β-defensins killed multiple bacterial species including drug-resistant ones, but lost antifungal activity when disulfide bonds were removed.
7-14 amino acidsshortened snake defensin-derived peptides retained antibacterial activity against 5 species including K. pneumoniae, but lost all antifungal capacity
What the researchers found
Linear beta-defensins from snakes were most active against E. coli, M. luteus, C. freundii, and S. aureus. Shorter derived peptides (7-14 amino acids) also showed antibacterial activity against those bacteria plus K. pneumoniae.
However, none of the derived peptides killed any of the four fungi tested (C. albicans, C. neoformans, T. rubrum, A. fumigatus). The key difference was the cysteine-to-serine substitution used to create the linear peptides. This suggests that the disulfide bridges formed by cysteines are essential for antifungal activity but less important for killing bacteria.
Adding tryptophan (an amino acid) to the derived peptides improved their antibacterial potency. The researchers concluded that while snake beta-defensins are not the most powerful antimicrobials, they serve as useful starting templates for designing new antibiotics.
Why it matters
Antibiotic resistance is a growing global problem. Venom-derived peptides are an underexplored source of new antibiotics. This study maps which structural features matter for antibacterial versus antifungal activity, guiding future peptide drug design.
The numbers in context
Active against E. coli, M. luteus, C. freundii, S. aureus, K. pneumoniae; inactive against 4 fungal species; 7-14 mer derived peptides
How the study worked
Researchers deduced peptide sequences from previously described beta-defensin genes in Brazilian snakes. They synthesized full-length peptides (~40 amino acids) and shorter derived peptides (7-14 amino acids) using bioisosterism (replacing cysteines with serines). They tested antimicrobial activity using microbroth dilution assays against multiple bacterial and fungal species.
Who was studied
Synthetic peptides tested against bacterial and fungal panels (in vitro)
What this study cannot tell us
All testing was done in lab conditions (in vitro). The peptides were not tested in animals or humans. The study only tested a limited panel of bacteria and fungi. The derived peptides had reduced overall potency compared to the full-length versions. No toxicity to human cells was assessed.
How to read the evidence
This is an in vitro screening study testing synthetic peptides against bacterial and fungal panels. It provides useful structure-activity relationship data but represents early-stage preclinical research without cytotoxicity, stability, or in vivo testing.
When this study was published
Published in late 2021, this study contributes to the growing field of reptile-derived antimicrobial peptide research, which has expanded significantly as the antibiotic resistance crisis intensifies.
The bigger picture
With antibiotic resistance growing, scientists are mining nature for new antimicrobial compounds. Snake venom and defense peptides are a largely unexplored resource. This study provides important structure-activity lessons — disulfide bonds are essential for antifungal activity but dispensable for antibacterial effects, and tryptophan enhances potency — that can guide the rational design of next-generation peptide antibiotics from reptilian templates.
Questions still open
- Could restoring disulfide bonds in the shortened peptides recover antifungal activity while maintaining the simpler structure?
- How do these snake β-defensin-derived peptides compare in potency to antimicrobial peptides from other animal sources?
- Would the tryptophan-enhanced variants show acceptable safety profiles for potential therapeutic development?
Common questions
What are β-defensins and why are snake versions interesting?
Why did removing disulfide bonds kill the antifungal activity but not the antibacterial activity?
Read the original research
Antimicrobial Activity of Snake β-Defensins and Derived Peptides.
Toxins, 14(1)
Citation
Oguiura, Nancy; Corrêa, Poliana Garcia; Rosmino, Isabella Lemos; de Souza, Ana Olívia; Pasqualoto, Kerly Fernanda Mesquita. (2021). Antimicrobial Activity of Snake β-Defensins and Derived Peptides.. Toxins, 14(1). https://doi.org/10.3390/toxins14010001